{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:50:35Z","timestamp":1790250635467,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Research"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>The aim of this study was to evaluate the correlation between hepatitis B core\u2010related antigen (HBcrAg) and hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) levels, and to investigate HBcrAg kinetics during nucleos(t)ide analogue (NA) or pegylated\u2010interferon (PEG\u2010IFN)\u2010\u03b1 treatment in a cohort of chronic hepatitis B (CHB) genotype D patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred thirty eight sequential serum samples were collected from 28 hepatitis B e antigen\u2010negative CHB genotype D patients (20\u00a0men and 8 women; median age, 54\u00a0years [range, 47\u201358\u00a0years]) who underwent NA (<jats:italic>n<\/jats:italic>\u2009=\u200920) or PEG\u2010IFN\u2010\u03b1 (<jats:italic>n<\/jats:italic>\u2009=\u20098) treatment. Serum HBcrAg levels were determined by chemiluminescent enzyme immunoassay. Longitudinal analysis was carried out at 6, 12, 24, and 36\u00a0months after NA treatment initiation and at 6, 12, and 18\u00a0months and at follow\u2010up month 6 after PEG\u2010IFN\u2010\u03b1 treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Basal HBcrAg levels were 4.7\u2009\u00b1\u20091.8\u00a0Log U\/mL and 3.3\u2009\u00b1\u20091.6\u00a0Log U\/mL in NA\u2010 and PEG\u2010IFN\u2010\u03b1\u2010treated patients, respectively. Hepatitis B core\u2010related antigen showed a moderate correlation with HBV DNA (<jats:italic>r<\/jats:italic>\u2009=\u20090.498, <jats:italic>P<\/jats:italic>\u2009&lt;\u00a00.0001) and no correlation with HBsAg (<jats:italic>r<\/jats:italic>\u2009=\u20090.192, <jats:italic>P<\/jats:italic>\u2009=\u20090.0669). In serial serum samples, a significant HBcrAg reduction was observed only in patients receiving NA (<jats:italic>P<\/jats:italic>\u2009=\u20090.019). In these patients, we observed a group (<jats:italic>n<\/jats:italic>\u2009=\u200912) with an early HBcrAg decline to undetectable levels between months 6\u201312, whereas the other group (<jats:italic>n<\/jats:italic>\u2009=\u20098) still had detectable HBcrAg at month 36 (4.4\u2009\u00b1\u20090.6\u00a0Log U\/mL), independently from HBV DNA and HBsAg kinetics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Serum HBcrAg correlates with HBV DNA levels, most likely through expression of viral replication activity. We observed two different HBcrAg kinetics in NA\u2010treated patients, suggesting different relapse risk related to NA cessation. Further studies on larger patient cohorts will elucidate the role of HBcrAg in the safe discontinuation of NA in CHB genotype D patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hepr.12811","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T01:52:42Z","timestamp":1472608362000},"page":"747-754","source":"Crossref","is-referenced-by-count":24,"title":["Hepatitis B core\u2010related antigen kinetics in chronic hepatitis B virus genotype D\u2010infected patients treated with nucleos(t)ide analogues or pegylated\u2010interferon\u2010\u03b1"],"prefix":"10.1111","volume":"47","author":[{"given":"Gian Paolo","family":"Caviglia","sequence":"first","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorena","family":"Abate","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Noviello","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Olivero","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rosso","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Troshina","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Citt\u00e0 della Salute e della Scienza Hospital  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ciancio","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"},{"name":"Department of Gastroenterology Citt\u00e0 della Salute e della Scienza Hospital  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rizzetto","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"},{"name":"Department of Gastroenterology Citt\u00e0 della Salute e della Scienza Hospital  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Maria","family":"Saracco","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Citt\u00e0 della Salute e della Scienza Hospital  Turin Italy"},{"name":"Department of Oncology University of Turin  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Smedile","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Turin  Turin Italy"},{"name":"Department of Gastroenterology Citt\u00e0 della Salute e della Scienza Hospital  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00139-9"},{"key":"e_1_2_6_4_1","first-page":"61","article-title":"Chronic hepatitis B therapy: available drugs and treatment guidelines","volume":"61","author":"Caviglia GP","year":"2015","journal-title":"Minerva Gastroenterol Dietol"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033364"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9365-4"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23190"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.65"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2013.08.010"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12444"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501564200"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21339"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12182"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12287"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12488"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00094.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.10.025"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02344.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12739"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.02.010"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.05.013"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.07.172"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12108"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12269"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22899"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12735"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21302"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22760"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04474.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9343-x"},{"key":"e_1_2_6_31_1","first-page":"1214A","article-title":"Serum hepatitis B core\u2010related antigen as a treatment predictor during pegylated interferon therapy in patients with HBeAg\u2010positive chronic hepatitis B","volume":"62","author":"Chuaypen N","year":"2015","journal-title":"Hepatology"},{"key":"e_1_2_6_32_1","first-page":"983A","article-title":"Hepatitis B core\u2010related antigen level decline in the first 12\u2009weeks of peginterferon treatment is associated with response in HBeAg\u2010negative chronic hepatitis B","volume":"62","author":"Campenhout MJ","year":"2015","journal-title":"Hepatology"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-015-1153-1"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1345717"}],"container-title":["Hepatology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhepr.12811","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhepr.12811","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hepr.12811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T14:52:34Z","timestamp":1696258354000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hepr.12811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/hepr.12811"],"URL":"https:\/\/doi.org\/10.1111\/hepr.12811","archive":["Portico"],"relation":{},"ISSN":["1386-6346","1872-034X"],"issn-type":[{"value":"1386-6346","type":"print"},{"value":"1872-034X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]}}}